Fantilanan, Marvie .

HRN: 15-73-46  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2024
CEFUROXIME 1.5GM (VIAL)
04/08/2024
04/08/2024
IV
1.5
Once
PTOR ELECTIVE CS
Waiting Final Action 
04/08/2024
CEFUROXIME 1.5GM (VIAL)
04/08/2024
04/09/2024
IV
1.5 Grams
Q8 X3 Doses
S/P CS
Waiting Final Action 
04/08/2024
CEFUROXIME 500MG (TAB)
04/09/2024
04/15/2024
PO
500mg
BID
S/P CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: